Teva Pharmaceutical Industries will pay a total of about $523 million to New York state to settle lawsuits that alleged the Israeli-based company had contributed to the opioid epidemic in the United States.
The $523 million total opioid payout to New York comprises two separate settlement agreements with Teva. The other settlement is a nationwide one reached in July that the company is working to finalize, valued at up to $4.25 billion. New York’s share of that amount is $210,548,226.20, according to Attorney General Letitia James’s office.
